Long Genes Over Expressed in Rett Syndrome
the Neurology Advisor take:
In Rett Syndrome, the absence of MeCP2 causes an over expression of long genes, according to a study published in Nature.
Scientists have already known that Rett Syndrome is caused by the absence of the MeCP2 protein, which regulates gene expression. However, they did not know which genes were affected. In this study, the researchers hoped to pinpoint the affected genes.
The researchers analyzed datasets of gene expression to search for patterns involving Rett Syndrome. They found that the genes disrupted in Rett Syndrome were often so-called long genes, or genes that are over 100,000 nucleotides in length.
After a more targeted analysis, the researchers found that the absence of MeCP2 increases the expression of long genes by 3% to 10%. Autopsied brains of people with Rett Syndrome confirmed the over expression of long genes. Additionally, they found that mice with Rett Syndrome that had more long genes had more severe symptoms.
The researchers also analyzed gene expression in MeCP2 Duplication Syndrome, where each cell has an extra copy of MeCP2. In this syndrome, they found that long genes are under expressed, providing further evidence that MeCP2 is integral for the regulation of long gene expression.
The researchers hope that their findings will create new avenues for treating Rett Syndrome and other MeCP2-related disorders. They have already begun testing topoisomerase inhibitors, a class of drugs that reduce long gene expression, in mice lacking MeCP2 with encouraging results.
In Rett syndrome, long genes are over expressed.
A new study suggests targeting long genes could be a new treatment avenue for the devastating childhood disorder Rett Syndrome. The authors found that lack of the MeCP2 protein that is the hallmark of the disease causes subtle - but widespread - overexpression of long genes with functions important for the brain.
Rett Syndrome is a brain development disease that begins to show symptoms within the first 12-18 months. The disease, which almost exclusively affect girls, involves a loss of intellectual, social and motor skills, accompanied by autistic behaviors, such as repetitive movement of the hands.
While it is believed that Rett Syndrome does not severely damage cognitive function, the disease deprives children of speech, hand use, and often the ability to walk. As development ensues, it brings anxiety, seizures, tremors, breathing difficulties, and severe gastrointestinal problems.
Next Article in Neurocognitive Disorders
Neurology Advisor Articles
- Ajovy Injection Approved for Migraine Prevention in Adults
- Few With Acute Migraine Take Triptans, Many Discontinue the Drug
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Magnesium Has No Effect on Cognitive Outcomes Following Aneurysmal Subarachnoid Hemorrhage
- Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD
- Combo Physical, Mental Activity Prevents Cognitive Decline
- Medicaid Expansion Linked to Gains in Insurance Coverage
- Folic Acid Supplementation May Protect Against Language Delay in AED-Exposed Children